---
title: "XAIR: Revenue grew to $7.7M and net loss narrowed, but going concern risk persists due to cash needs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291003295.md"
description: "Revenue more than doubled to $7.7M, with net loss narrowing to $33.2M as cost controls improved. Despite progress in commercialization and new financing, substantial doubt remains about the company's ability to continue as a going concern due to ongoing losses and limited cash runway.Original document: Beyond Air, Inc. [XAIR] SEC 10-K Annual Report — Jun. 26 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-06-26T20:07:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291003295.md)
  - [en](https://longbridge.com/en/news/291003295.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291003295.md)
generator: "portal-rs"
---

# XAIR: Revenue grew to $7.7M and net loss narrowed, but going concern risk persists due to cash needs

Revenue more than doubled to $7.7M, with net loss narrowing to $33.2M as cost controls improved. Despite progress in commercialization and new financing, substantial doubt remains about the company's ability to continue as a going concern due to ongoing losses and limited cash runway.

Original document: Beyond Air, Inc. \[XAIR\] SEC 10-K Annual Report — Jun. 26 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [XAIR.US](https://longbridge.com/en/quote/XAIR.US.md)

## Related News & Research

- [Beyond Air to present at Cantor Global Healthcare Conference](https://longbridge.com/en/news/297782505.md)
- [Beyond Air says FDA grants Breakthrough Device tag for LungFit GO in NTM lung disease](https://longbridge.com/en/news/297513609.md)
- [Berkshire Hathaway CEO Sees Alphabet as Key Participant in AI Sector After USD17B Stake Increase in 2Q](https://longbridge.com/en/news/297844672.md)
- [Faraday Future signs compliance, localization advisory deal with AIBOT](https://longbridge.com/en/news/297855575.md)
- [XAIR: Flat revenue, improved margins, and strong outlook hinge on FDA approval and new product launch](https://longbridge.com/en/news/295788812.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**